Applied DNA Sciences, Inc. Strategic Asset Allocation Index
Applied DNA Sciences, Inc. strategic asset allocation index. Applied DNA Sciences, Inc. (BNBX) has a Strategic Asset Allocation Index of 44.5% as of March 2026. Strategic assets (PP&E of $- plus long-term investments of $5.40 Million) total $5.40 Million, measured against net assets of $12.13 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Applied DNA Sciences, Inc.'s balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Applied DNA Sciences, Inc. Strategic Asset Allocation Index by Year (None–None)
Applied DNA Sciences, Inc. strategic asset allocation index by year from None to None. The table below presents the year-by-year Strategic Asset Allocation Index for Applied DNA Sciences, Inc. from None to None, covering 0 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see BNBX market cap.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|